Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 16.51 USD 0.61% Market Closed
Market Cap: 2.4B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of DNLI.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DNLI Intrinsic Value
Not Available
Base Case Scenario
Compare DNLI to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DNLI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Denali Therapeutics Inc

Current Assets 934.7m
Cash & Short-Term Investments 899m
Other Current Assets 35.8m
Non-Current Assets 231.5m
Long-Term Investments 78.5m
PP&E 130.1m
Other Non-Current Assets 23m
Current Liabilities 91.1m
Accounts Payable 10.8m
Accrued Liabilities 60.4m
Other Current Liabilities 19.9m
Non-Current Liabilities 48.1m
Long-Term Debt 5.6m
Other Non-Current Liabilities 42.6m
Efficiency

Free Cash Flow Analysis
Denali Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Denali Therapeutics Inc

Revenue
0 USD
Operating Expenses
-534m USD
Operating Income
-534m USD
Other Expenses
55.1m USD
Net Income
-478.9m USD
Fundamental Scores

DNLI Profitability Score
Profitability Due Diligence

Denali Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Declining ROE
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
hidden
Profitability
Score

Denali Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

DNLI Solvency Score
Solvency Due Diligence

Denali Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Denali Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DNLI Price Targets Summary
Denali Therapeutics Inc

Wall Street analysts forecast DNLI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DNLI is 32.48 USD with a low forecast of 24.24 USD and a high forecast of 42 USD.

Lowest
Price Target
24.24 USD
47% Upside
Average
Price Target
32.48 USD
97% Upside
Highest
Price Target
42 USD
154% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Denali Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DNLI is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DNLI Insider Trading
Buy and sell transactions by insiders